(Q32134)
Statements
Sexual health and sexual function are critical to the wellbeing of cisgender, transgender, and gender diverse populations. (English)
PURPOSE OF REVIEW (English)
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved. (English)
2024
To date, there has been only limited patient-focused evaluation of sexual function in transgender and gender diverse patients at several stages in their gender-affirming medical care. (English)
PURPOSE OF REVIEW (English)
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved. (English)
2024
There remains a need to better understand the impact of gender affirming medical and surgical therapy on sexual health, and to develop evidence-based treatments to address sexual dysfunction when present. (English)
PURPOSE OF REVIEW (English)
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved. (English)
2024
The impact of gender-affirming hormone therapy on sexual health is complex and evolves over time on treatment. (English)
RECENT FINDINGS (English)
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved. (English)
2024
Despite high incidences of complications, major genital gender-affirming surgeries such as vulvovaginoplasty and penile implant placement after phalloplasty yield high patient satisfaction. (English)
RECENT FINDINGS (English)
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved. (English)
2024
While treatments to preserve or restore erections and to improve vaginal lubrication have been trialed based upon literature in cisgender populations, there remains minimal evidence to guide medical treatment of sexual dysfunction ranging from erectile dysfunction to dyspareunia. (English)
RECENT FINDINGS (English)
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved. (English)
2024
There is a continued need for ongoing efforts to develop patient-reported outcome measures and rigorous investigation of sexual health preservation and restoration treatments in transgender and gender diverse populations. (English)
SUMMARY (English)
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved. (English)
2024
Xinyuan (English)
Zhang (English)
X
Paul (English)
Neuville (English)
P
Alexander J (English)
Skokan (English)
AJ
6 August 2024
6 August 2024